Ascendis Pharma A/S Ordinary Share (ASND) Stock Forecast — 2-Week Outlook

StockMap's current 2-week read on Ascendis Pharma A/S Ordinary Share (ASND) is Neutral.

The composite score behind that read is +0.08, weighing +0.11 of bullish evidence against -0.27 bearish.

Ascendis Pharma A/S Ordinary Share last closed at $229.23, +2.94% on the session.

Against the IVW growth benchmark the position is +2.14% over the forecast window.

The read is built from 15 underlying insights — 11 bullish and 4 bearish.

Agreement across those insights is 73%.

4 graded predictions for ASND so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.

On the fundamentals StockMap ranks Ascendis Pharma A/S Ordinary Share in the 54th percentile on valuation and the 97th percentile on return on equity, where 100 is best.

Ascendis Pharma A/S Ordinary Share is classified under Health Care / Biotechnology, with a market capitalisation of $14.79B.

StockMap tracks Ascendis Pharma A/S Ordinary Share as the 18th largest of the 381 companies it covers in the Biotechnology industry, part of the Health Care sector.

Across that group the current two-week reads are 301 Neutral, 63 Moderate Underperform and 17 Moderate Outperform.

On that composite Ascendis Pharma A/S Ordinary Share ranks 48th of 381 in the group, against a group median of -0.08.